Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 09-2004 | 06-2004 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 850 | 1,040 | 6 |
| Other current assets | 90 | 50 | 4 |
| TOTAL | $940 | $1,090 | $10 |
| Non-Current Assets | |||
| PPE Net | 520 | 10 | N/A |
| Other Non-Current Assets | 26,790 | 180 | 180 |
| TOTAL | $27,310 | $190 | $180 |
| Total Assets | $28,070 | $1,290 | $200 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,180 | 190 | 160 |
| Accrued Expenses | 230 | 100 | 40 |
| Other current liabilities | 360 | 290 | 0 |
| TOTAL | $4,880 | $710 | $340 |
| Non-Current Liabilities | |||
| Long Term Debt | 0 | 10 | 0 |
| TOTAL | $N/A | $10 | $N/A |
| Total Liabilities | $4,880 | $720 | $340 |
| Shareholders' Equity | |||
| Common Shares | 500 | 370 | 360 |
| Retained earnings | -4,740 | -1,970 | -1,340 |
| Other shareholders' equity | -10 | -10 | 10 |
| TOTAL | $23,190 | $560 | $-140 |
| Total Liabilities And Equity | $28,070 | $1,280 | $200 |